Fibromyalgia is not psychosomatic in the traditional sense of the word. It was once dismissed as a psychological condition, but decades of research have revealed measurable changes in how the brain and nervous system process pain. Brain imaging shows structural differences, cerebrospinal fluid contains abnormal levels of pain-signaling chemicals, and up to half of fibromyalgia patients show physical nerve damage on skin biopsies. The picture is more complicated than “real” versus “imagined,” though, and understanding why takes a closer look at what’s actually happening in the body.
Why Fibromyalgia Got the Psychosomatic Label
The psychosomatic reputation goes back to the 1950s, when fibromyalgia emerged as a diagnosis for widespread pain that doctors couldn’t explain with standard tests. Early physicians saw it as a musculoskeletal pain problem frequently tied to “psychosomatic factors” and “life situations,” often assuming it would disappear once emotional stress resolved. Some warned that giving patients a physical diagnosis for what they believed was an emotional problem merely created “an aura of organicity about the psychogenic disorder.”
That skepticism lingered for decades, partly because fibromyalgia doesn’t show up on X-rays, blood tests, or other conventional diagnostics. Without a visible injury or inflammation site, many clinicians defaulted to a psychological explanation. It wasn’t until the late 1970s that researchers began documenting measurable differences in pain thresholds, and not until the 1990s and 2000s that brain imaging and neurochemistry studies started building a biological case.
What Brain Scans Actually Show
Functional MRI studies have identified hyperactivity in multiple brain regions involved in pain processing, including the insular cortex and cerebellum. These aren’t subtle findings. People with fibromyalgia show increased functional connectivity between the brain’s default mode network and pain-related areas, meaning pain circuits are more tightly wired together and more active than in healthy individuals.
Structural scans tell a similar story. Grey matter volume is reduced in the prefrontal cortex and posterior cingulate cortex, regions involved in regulating pain and emotion. Cortical thickness is decreased across parts of the frontal, temporal, and parietal cortex. White matter pathways, the brain’s communication cables, also show measurable changes. These are objective, physical differences visible on imaging. They aren’t something a person can produce through worry or stress alone.
The Neurochemistry Behind the Pain
The most consistent finding in fibromyalgia research involves a concept called central sensitization: the nervous system’s volume knob for pain gets turned up and stuck there. In practical terms, signals that a healthy nervous system would register as mild pressure or normal sensation get amplified into pain.
This happens through specific, measurable chemical changes. People with fibromyalgia have elevated levels of substance P and glutamate, two chemicals that ramp up pain signaling, in their cerebrospinal fluid. At the same time, they have lower levels of serotonin and norepinephrine in the spinal pathways responsible for dampening pain. So the system that amplifies pain is overactive, and the system that quiets pain is underperforming. Dopamine regulation and the brain’s natural opioid activity are also disrupted.
On top of this, researchers have found elevated inflammatory markers in both blood and cerebrospinal fluid. Immune cells called microglia, which act as the brain’s maintenance crew, become overactivated and release chemicals that keep neurons in a hyperexcitable state. This neuroinflammation contributes to the cycle of central sensitization.
Physical Nerve Damage in Some Patients
One of the more striking findings in recent years involves small fiber neuropathy, a condition where the tiny nerve fibers in the skin are physically damaged or reduced in number. Studies show that up to 45 to 50 percent of fibromyalgia patients test positive for small fiber neuropathy on skin biopsy. In one clinical rheumatology practice, 77 percent of patients who tested positive for this nerve damage also carried a fibromyalgia diagnosis. This is tissue-level, biopsy-confirmed pathology, as far from “imagined” as a medical finding can get.
The New Medical Term: Nociplastic Pain
The International Association for the Study of Pain created a category specifically to describe conditions like fibromyalgia: nociplastic pain. This is defined as pain arising from altered pain processing in the nervous system, without the kind of tissue damage or nerve injury that explains traditional pain types. It’s a third category alongside nociceptive pain (from injury) and neuropathic pain (from nerve damage), and it formally recognizes that the nervous system itself can malfunction in ways that produce genuine, severe pain.
This distinction matters because nociplastic pain is specifically different from psychogenic pain. Research published in The Korean Journal of Pain notes that fibromyalgia produces measurable hypersensitivity to touch, pressure, movement, and temperature. Psychogenic pain does not. The two can be clinically distinguished, and fibromyalgia falls on the neurological side of that line.
The World Health Organization’s current International Classification of Diseases (ICD-11) classifies fibromyalgia under chronic primary pain, not under mental health conditions.
Genetics Play a Role
Fibromyalgia runs in families, and researchers have identified several genes that likely contribute to risk. These genes are involved in the production and breakdown of neurotransmitters, the same chemical messengers found at abnormal levels in fibromyalgia patients. No single gene causes the condition. Instead, small variations in multiple genes appear to combine, each nudging the nervous system’s pain processing slightly toward dysfunction. This genetic component further undermines the idea that fibromyalgia is purely psychological.
Where Psychology Does Fit In
None of this means psychological factors are irrelevant. The current scientific framework for fibromyalgia is biopsychosocial, meaning biological, psychological, and social factors all interact and influence each other. Stress, trauma, mood, sleep, and social circumstances can all dial the nervous system’s sensitivity up or down. Levels of the stress hormone CRH in cerebrospinal fluid correlate with pain severity, and those CRH levels are themselves strongly linked to a history of early-life physical or sexual abuse.
The key distinction is that psychological factors modulate fibromyalgia rather than create it from nothing. Stress doesn’t cause pain in a healthy nervous system the way it does in one that’s already primed by central sensitization, neuroinflammation, and altered neurochemistry. Emotional distress and pain catastrophizing have measurable effects on functional brain responses to pain, meaning they change real neural activity, not just a person’s attitude. Psychological and social factors aren’t secondary reactions to pain either. They form part of the interactive system that keeps the condition going.
This is why treatments for fibromyalgia that combine physical, psychological, and pharmacological approaches tend to work better than any single strategy. Cognitive behavioral therapy helps not because the pain is imaginary but because changing how the brain processes threat and stress can reduce the neural amplification that drives symptoms. Exercise works similarly, gradually recalibrating the nervous system’s sensitivity over time.
What “Psychosomatic” Gets Wrong
The word psychosomatic implies that a condition originates in the mind and that the body is merely following orders from an anxious or distressed brain. Fibromyalgia doesn’t fit that description. It involves structural brain changes, neurochemical imbalances, immune system activation, genetic predisposition, and in many cases, measurable nerve fiber loss. Psychological factors interact with all of these, but they don’t explain the condition on their own any more than stress explains a heart attack in someone with clogged arteries. The biology is real, it’s measurable, and it’s increasingly well understood.